New ETF Book by Larry Connors - Click here to read more
Telemedicine, which allows medical professionals to monitor or treat patients even when they are not in the same location, is widely recognized as an essential step in reducing the escalating cost of healthcare. Instead of entering a hospital or visiting a doctor for check-ups, the patient wears a small device that continually monitors a number of relevant physiological parameters. This approach has many potential benefits, including maintaining wellness, earlier detection of developing health conditions, improving lifestyle, and lowering healthcare costs.
"Mayo Clinic has always committed the best available resources to caring for patients with cardiovascular disease. This collaboration, by enhancing our ability to record important physiologic information while patients are outside the medical environment and active in their daily lives, will extend our ability to prevent and treat illness," said Paul Friedman, M.D., a cardiology consultant and specialist in cardiovascular electrophysiology at Mayo Clinic, who added that an initial program of patient trials is already underway.
This platform is the result of an R&D collaboration that combines ST's expertise in developing innovative solutions using its advanced sensor, microprocessor and communication products and Mayo Clinic's best-in-class medical expertise. It uses a combination of sensors, ultra-low-power microcontroller and wireless modules, and interfaces to provide information about the patient's heart rate, breathing rate, physical activity and other measurements wirelessly obtained from external medical devices.
"Combining the worldwide recognized clinical expertise of Mayo Clinic with our ability to provide highly integrated volume solutions at affordable costs, we are convinced we will open new frontiers to bring quality healthcare to everybody," said Alessandro Cremonesi, Vice President, Advanced System Technology, STMicroelectronics. "ST is utilizing its strong expertise to develop advanced technologies and products satisfying the requirements of telemedicine platforms. This will allow medical device manufacturers and health-care providers to develop new products and services to enhance the quality of medical support for their customers and patients."
Telemedicine is expected to play an increasingly important role in helping solve the growing costs of healthcare monitoring and delivery, especially in the context of an aging population. For example, in the USA, which spent over $2 trillion on healthcare in 2007 - nearly twice the average per-capita spending of other developed countries - the Congressional Budget Office estimates that, with current trends, by 2025 some 25% of the national economy will be tied up in healthcare.(1)
In addition to better service to the patient, the potential benefits of remote monitoring may include:
-- lower costs due to reduced physician visits for routine check-ups;
-- earlier diagnosis of impending health problems, leading to earlier
intervention, in turn reducing hospitalization, costs and enhancing the
probability of successful recovery from illness;
-- lower environmental burden due to reduced necessity for travel;
-- acquisition of comprehensive and integrated data for epidemiology, drug
safety, and other research studies to advance medical knowledge
regarding diseases.
Remote monitoring thus offers important opportunities to reduce healthcare costs and enhance patients' quality of life.
Further description of the platform for remote monitoring is available at
http://www.mayoclinic.org/medical-edge-television-2009
About Mayo Clinic Office of Intellectual Property
Mayo Clinic has one of the most highly evolved intellectual property and technology commercialization efforts in academic medicine, with a 20 plus year history of supporting Mayo's mission. The Office of Intellectual Property at Mayo Clinic, serves as a bridge between discoveries and the marketplace. The Office works closely with Mayo physicians and scientists to evaluate and develop inventions, ideas and discoveries that have the potential to transform healthcare and generate income to support Mayo patient care, education and research. Mayo Clinic's Office of Intellectual Property has filed more than 2,400 patents resulting in over 600 active patent-licensing agreements with industry.
About STMicroelectronics
STMicroelectronics is a global leader serving customers across the spectrum of electronics applications with innovative semiconductor solutions. ST aims to be the undisputed leader in multimedia convergence and power applications leveraging its vast array of technologies, design expertise and combination of intellectual property portfolio, strategic partnerships and manufacturing strength. In 2008, the Company's net revenues were $9.84 billion. Further information on ST can be found at www.st.com.
Note for editors
Neither Mayo Clinic nor its investigators will receive any payment for the use of products developed via this collaboration in clinical trials with Mayo Clinic patients.
(1) http://www.whitehouse.gov/issues/health-care
SOURCE STMicroelectronics
http://www.st.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.